The authors use household-level data and hourly industry data from Mexico to show how more efficient pricing mechanisms, combined with well-designed environmental regulations, can significantly improve economic, social and environmental outcomes.
Juan Rosellón, Pedro Hancevic, Hector NuñezJuly 6, 2021
Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.
It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. Robust stakeholder engagement preceded adoption of the fourteen‐day limit and should arguably be part of efforts to reassess it, write the authors.
Kirstin R.W. Matthews, Ana S. Iltis, Daniel S. Wagner, Nuria Gallego Marquez, Jason Scott Robert, Inmaculada de Melo-Martín, Marieke Bigg, Sarah Franklin, Soren Holm, Ingrid Metzler, Matteo A. Molè, Jochen Taupitz, Giuseppe Testa, Jeremy SugarmanFebruary 26, 2021
This study leverages validated patient-reported outcomes measures to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons
Anaeze C. Offodile II, Christopher J. Coroneos, Yu-Li Lin, Chris Sidey-Gibbons, Malke Asaad, Brian Chin, Stefanos Boukovalas, Margaret S. Roubaud, Makesha Miggins, Donald P. BaumannDecember 21, 2020
Existing innovation in outcomes measurement and resource management, coupled with the competitive pressures of Covid-19, create a unique window for value creation within surgical care, the authors write. Read their article in the Annals of Surgery.
Anaeze C. Offodile II, Kushal T. Kadakia, Lee Fleisher, C.J. Stimson, Thomas AloiaJuly 26, 2020
The authors found that six months of pre–end-stage kidney disease nephrology care did not significantly improve the likelihood that patients would remain employed when they started dialysis. This finding underscores the need to identify effective methods to help patients stay employed when they transition to dialysis.
Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.
Sayna Norouzi, Bo Zhao, Ahmed Awan, Wolfgang Winkelmayer, Vivian Ho, Kevin EricksonFebruary 5, 2020
Consolidated dialysis markets have coincided with both positive and negative trends in health care costs and outcomes. If the underlying mechanisms that contributed to past consolidation persist, dialysis markets may remain highly concentrated over the long term.
Maryam Saeed, Vivian Ho, Kevin EricksonJanuary 12, 2020